| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |